Furthermore, besides promoting leukemia, G-CSFR signaling can be responsible for the progression and metastasis of several tumors, and was shown as a potential target for treating glial [76,77], bladder [25], colon [21], ovary [22], and breast [23,24] cancers. The gene discussed is CSF3R; the disease is leukemia.